Gara Jalqabaatti › Burkitt Lymphoma
Qorannoo klinikaalii Burkitt Lymphoma Ameerikaa Keessatti hirmaatuu
Qorannoo 63 Burkitt Lymphoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 21
- Philadelphia, PAQorannoo 16
- Milwaukee, WIQorannoo 16
- Chicago, ILQorannoo 15
- Cincinnati, OHQorannoo 13
- New York City, NYQorannoo 13
- Atlanta, GAQorannoo 12
- Aurora, COQorannoo 11
- Seattle, WAQorannoo 11
- Durham, NCQorannoo 10
- Boston, MAQorannoo 10
- Kansas City, MOQorannoo 10
- Los Angeles, CAQorannoo 10
- Minneapolis, MNQorannoo 9
- Orange, CAQorannoo 9
- Washington, DCQorannoo 9
- Baldwin Park, CAQorannoo 9
- Nashville, TNQorannoo 8
- Ann Arbor, MIQorannoo 8
- San Francisco, CAQorannoo 8
- Buffalo, NYQorannoo 8
- Baltimore, MDQorannoo 8
- Columbus, OHQorannoo 8
- Portland, ORQorannoo 8
- Greenburgh, NYQorannoo 7
- Birmingham, ALQorannoo 7
- Oklahoma City, OKQorannoo 7
- Cleveland, OHQorannoo 7
- Grand Rapids, MIQorannoo 7
- San Antonio, TXQorannoo 7
- Richmond, VAQorannoo 7
- Dallas, TXQorannoo 7
- Providence, RIQorannoo 7
- Jacksonville, FLQorannoo 7
- Tampa, FLQorannoo 7
- Clifton, NJQorannoo 7
- Salt Lake City, UTQorannoo 7
- St. Petersburg, FLQorannoo 6
- Pittsburgh, PAQorannoo 6
- Winston-Salem, NCQorannoo 6
Naannoon
- AlabamaQorannoo 7
- ArizonaQorannoo 7
- ArkansasQorannoo 5
- CaliforniaQorannoo 20
- ColoradoQorannoo 14
- ConnecticutQorannoo 7
- DelawareQorannoo 7
- Distaarikii KoloombiyaaQorannoo 5
- FloridaQorannoo 15
- GeorgiaQorannoo 12
- HawaiiQorannoo 5
- IdahoQorannoo 6
- IllinoisQorannoo 15
- IndianaQorannoo 6
- IowaQorannoo 7
- KansasQorannoo 6
- KentuckyQorannoo 5
- LouisianaQorannoo 4
- MaineQorannoo 4
- MarylandQorannoo 11
- MassachusettsQorannoo 10
- MichiganQorannoo 10
- MinnesotaQorannoo 10
- MississippiQorannoo 4
- MissouriQorannoo 8
- NebraskaQorannoo 5
- NevadaQorannoo 6
- New HampshireQorannoo 4
- New JerseyQorannoo 8
- New MexicoQorannoo 3
- New YorkQorannoo 19
- North CarolinaQorannoo 13
- North DakotaQorannoo 5
- OhioQorannoo 18
- OklahomaQorannoo 7
- OregonQorannoo 8
- PennsylvaniaQorannoo 18
- Rhode IslandQorannoo 7
- South CarolinaQorannoo 5
- South DakotaQorannoo 5
- TennesseeQorannoo 10
- TexasQorannoo 24
- UtahQorannoo 7
- VermontQorannoo 3
- VirginiaQorannoo 7
- WashingtonQorannoo 11
- West VirginiaQorannoo 3
- WisconsinQorannoo 17
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07223021A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 18 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06173518A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
366 Days – 46 Years · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06124157Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 39 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT03150693Blinatumomab Consolidation in Real World
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07117136Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 0 hanga 38 · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06131801CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT05442515Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT03739814Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT03223610Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Namoota walitti qabaa jiraSadarkaa 2
365 Days · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06317662Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06144606Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07648264Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06395103UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Namoota walitti qabaa jiraSadarkaa 1/2
31 Days – 30 Years · Saalaa hunda · Haaromfame 14-Ful-2026 · NCT04544592Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT03666000A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT04546399Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Namoota walitti qabaa jiraSadarkaa 3
365 Days – 25 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT03959085Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05389423AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06137118Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 7 hanga 25 · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT05082519Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06710418AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06340737Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 15 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT03136146Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel as a Consolidation in Patients With Relapsed/Refractory (R/R) and Newly Diagnosed B-cell Acute Lymphocytic Leukemia (ALL) Post Cytoreduction With Mini-HCVD-inotuzumab-blinatumomab/HCVAD-inotuzumab-blinatumomab
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Hag-2026 · NCT06287229LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 81 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05990465Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.